PuSH - Publikationsserver des Helmholtz Zentrums München

Emerging targets in type 2 diabetes and diabetic complications.

Adv. Sci., e2100275 (2021)
Verlagsversion DOI
Open Access Gold
Creative Commons Lizenzvertrag
Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications.
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Insulin Resistance ; Metabolism ; Signaling Pathways ; Type 2 Diabetes, Diabetic Complications; Magnetic-resonance Neurography; Improves Insulin Sensitivity; Intensive Glucose Control; Beta-cell Dysfunction; Kidney-disease; Microvascular Complications; Metabolic Memory; Adipose-tissue; In-vivo; Multifactorial Intervention
ISSN (print) / ISBN 2198-3844
e-ISSN 2198-3844
Zeitschrift Advanced science
Quellenangaben Band: , Heft: , Seiten: e2100275 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort Weinheim
Begutachtungsstatus Peer reviewed
Förderungen German Research Foundation (DFG)
Collaboration Research Center (CRC)